Oncogenic Ras suppresses Cdk1 in a complex manner during the incubation of activated Xenopus egg extracts

被引:5
作者
Huang, Tun-Lan [1 ]
Pian, Jerry P. [1 ]
Pan, Bin-Tao [1 ,2 ,3 ,4 ]
机构
[1] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY 40536 USA
[2] Univ Kentucky, Coll Med, Dept Neurosurg, Lexington, KY 40536 USA
[3] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA
[4] Univ Kentucky, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA
关键词
Signal transduction; Oncogenic Ras; Cdk1; Cell cycle arrest; Xenopus egg extracts; CELL-CYCLE ARREST; PROTEIN-KINASE; MAP KINASE; IN-VITRO; M-PHASE; CDC2; PROTEIN; P90; RSK; UBIQUITIN; PHOSPHORYLATION; PHOSPHATASE;
D O I
10.1016/j.abb.2013.01.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activity of Cdk1 is the driving force for entry into M-phase during the cell cycle. Activation of Cdk1 requires synthesis and accumulation of cyclin B, binding of cyclin B to Cdk1, and removal of the inhibitory tyr-15-Cdk1 phosphorylation. It was previously shown that oncogenic Ras suppresses Cdk1 activation during the incubation of activated Xenopus egg extracts. However, how oncogenic Ras suppresses Cdk1 remained unclear. Using the histone H1 kinase assay to follow Cdk1 activity and Western blot analysis to assess levels of both cyclin B2 and phosphorylated-tyr-15-Cdk1, how oncogenic Ras suppresses Cdk1 is studied. The results indicate that oncogenic Ras suppresses Cdk1 via induction of persistent phosphorylation of tyr-15-Cdk1. Interestingly, the results reveal that, compared with cyclin B2 in control activated egg extracts, which increased, peaked and then declined during the incubation, oncogenic Ras induced continuous accumulation of cyclin B2. The results also indicate that oncogenic Ras induces continuous accumulation of cyclin B2 primarily through stabilization of cyclin B2, which is mediated by constitutive activation of the Raf-Mek-Erk-p90(rsk) pathway. Taken together, these results indicate that oncogenic Ras suppresses Cdk1 in a complex manner: It induces continuous accumulation of cyclin B2, but also causes persistent inhibitory phosphorylation of tyr-15-Cdk1. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:61 / 72
页数:12
相关论文
共 60 条
[1]   MAPK inactivation is required for the G(2) to M-phase transition of the first mitotic cell cycle [J].
Abrieu, A ;
Fisher, D ;
Simon, MN ;
Doree, M ;
Picard, A .
EMBO JOURNAL, 1997, 16 (21) :6407-6413
[2]   Cloning and characterization of Xenopus Rsk2, the predominant p90 Rsk isozyme in oocytes and eggs [J].
Bhatt, RR ;
Ferrell, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) :32983-32990
[3]   The protein kinase p90 Rsk as an essential mediator of cytostatic factor activity [J].
Bhatt, RR ;
Ferrell, JE .
SCIENCE, 1999, 286 (5443) :1362-1365
[4]   Activation of the p42 mitogen-activated protein kinase pathway inhibits Cdc2 activation and entry into M-phase in cycling Xenopus egg extracts [J].
Bitangcol, JC ;
Chau, ASS ;
Stadnick, E ;
Lohka, MJ ;
Dicken, B ;
Shibuya, EK .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (02) :451-467
[5]   Activation of Xenopus eggs by the kinase inhibitor 6-DMAP suggests a differential regulation of cyclin B and p39mos proteolysis [J].
Bodart, JF ;
Béchard, D ;
Bertout, M ;
Gannon, J ;
Rousseau, A ;
Vilain, JP ;
Flament, S .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (02) :413-421
[6]   Dual-specific Cdc25B phosphatase: In search of the catalytic acid [J].
Chen, W ;
Wilborn, M ;
Rudolph, J .
BIOCHEMISTRY, 2000, 39 (35) :10781-10789
[7]   Phosphorylation of Cdc25C by pp90Rsk contributes to a G2 cell cycle arrest in Xenopus cycling egg extracts [J].
Chun, J ;
Chau, ASS ;
Maingat, FG ;
Edmonds, SD ;
Ostergaard, HL ;
Shibuya, EK .
CELL CYCLE, 2005, 4 (01) :148-154
[8]   THE RAS ONCOPROTEIN AND M-PHASE ACTIVITY [J].
DAAR, I ;
NEBREDA, AR ;
YEW, N ;
SASS, P ;
PAULES, R ;
SANTOS, E ;
WIGLER, M ;
VANDEWOUDE, GF .
SCIENCE, 1991, 253 (5015) :74-76
[9]  
Dorée M, 2002, J CELL SCI, V115, P2461
[10]   Targeting ras signalling pathways in cancer therapy [J].
Downward, J .
NATURE REVIEWS CANCER, 2003, 3 (01) :11-22